Swiss drugmaker Novartis to invest $23bn in US manufacturing and R&D

Swiss drugmaker Novartis to invest $23bn in US manufacturing and R&D

FT.com

Published

Pharma group builds out American supply chains as part of preparations for potential US tariffs

Full Article